TNK BIOTECH ApS: Financial statements 2017
CVR: 30691911
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
TNK BIOTECH ApS (CVR 30691911) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -9,523 and a net result of DKK -13,840 compared with DKK -11,322 the year before. Equity in the 2017 report amounted to DKK 22,676. The solvency ratio was 71.2%.
- Gross Profit
- DKK -9,523
- Profit/Loss
- DKK -13,840
- Equity
- DKK 22,676
- Total Assets
- DKK 31,829
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -10 t. | -14 t. | 23 t. | - |
| 2016 | - | -10 t. | -11 t. | 37 t. | - |
| 2015 | - | -32 t. | -41 t. | 48 t. | - |
| 2014 | - | -8 t. | -11 t. | 88 t. | - |
| 2013 | - | 269 t. | 75 t. | 99 t. | - |
Official annual report
Keep an eye on TNK BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
TNK BIOTECH ApS has published its annual report for 2016. Gross profit came to DKK -9,548, and the net result was DKK -11,322.
About TNK BIOTECH ApS
TNK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2007. The company is registered under the industry Investering for egen regning. The company was previously named TNK INVEST ApS. The management consists of Thomas Nitschke Kledal. The company is owned by Thomas Nitschke Kledal. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK -11,363 and a net result of DKK -17,528 compared with DKK -15,724 the year before. Equity in the 2025 report amounted to DKK -82,154.